Neutrophil/lymphocyte ratio as surrogate of cetuximab antibody-dependent cell-mediated cytotoxicity in first line metastatic colorectal cancer: A preliminary and exploratory analysis of the ERMES phase III trial.
作者： Maria Alessandra Calegari , Armando Orlandi , Michele Basso , Carmela Di Dio , Maria Bensi
DOI: 10.1200/JCO.2018.36.15_SUPPL.E15656
关键词:
摘要: e15656Background: The ERMES trial is an ongoing phase III RCT comparing standard treatment with FOLFIRI+Cetuximab (Cet) until PD (arm A) to de-escalating Cet monotherapy after 4 months of induction...
sci-hub.st 参考文章(0)